Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.

@article{Kawamura2017UsefulnessAL,
  title={Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.},
  author={Yusuke Kawamura and Kenji Ikeda and Shunichiro Fujiyama and Tetsuya Hosaka and Masahiro Kobayashi and Satoshi Saitoh and Hitomi Sezaki and Norio Akuta and Fumitaka Suzuki and Yoshiyuki Suzuki and Yasuji Arase and Hiromitsu Kumada},
  journal={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2017},
  volume={47 4},
  pages={338-346}
}
AIM The aim of this study is to clarify the usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization (B-TACE) using miriplatin for patients with four or fewer hepatocellular carcinoma (HCC) nodules. METHODS We studied 47 nodules in 30 consecutive patients who received miriplatin by B-TACE to treat HCC with four or fewer… CONTINUE READING